EU Regulator To Re-Examine Safety Of Common Drugs
The European Medicines Agency (EMA) said on Tuesday that it was launching a new review on non-selective non-steroidal anti-inflammatory drugs (NSAIDs), reversing an earlier stance that gave NSAIDs a clean bill of health.
EMA will present a scientific opinion next month to address the benefit-risk profile of the drugs, the agency said.
NSAIDs are widely used to treat arthritis and other painful...
To view the full article, register now.